Discussion about this post

User's avatar
Obsidian Research's avatar

Overreaction or not, this is still a huge red flag. The AMF doesn’t launch investigation for no reason. He may be a good capital allocator and have a solid growth road map, but this clearly highlights a huge flaw in terms of governance. I wouldn’t touch this company despite being a good compounding machine. We’ll see how it plays out, but governance issues like these shouldn’t be ignored. Cheers!

2 more comments...

No posts

Ready for more?